Pfizer Touts Elrexfio’s Potential For Community Oncology Use In Myeloma

Second Approval Of BCMA-Directed Bispecific Antibody

 
• By Alaric DeArment
  
Pfizer announced the approval of anti-BCMA bispecific antibody Elrexfio for multiple myeloma • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip